TreeWAS – Variant ID: rs286905

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Y52.1 Calcium-channel blockers	0.000	0.988	0.012
Y52 Agents primarily affecting the cardiovascular system	0.000	0.989	0.011
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.000	0.990	0.010
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.000	0.990	0.010
Y54.3 Benzothiadiazine derivatives	0.000	0.990	0.010
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.990	0.010
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.990	0.010
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.990	0.010
Y52.4 Angiotensin-converting-enzyme inhibitors	0.000	0.991	0.009
Y57.9 Drug or medicament, unspecified	0.000	0.991	0.009
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.000	0.991	0.009
Y57 Other and unspecified drugs and medicaments	0.000	0.991	0.009
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.991	0.009
Y52.7 Peripheral vasodilators	0.000	0.991	0.009
Y42.7 Androgens and anabolic congeners	0.000	0.991	0.009
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.000	0.991	0.009
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.992	0.008
Y57.8 Other drugs and medicaments	0.000	0.992	0.008
Y42.0 Glucocorticoids and synthetic analogs	0.000	0.992	0.008
Y52.8 Antivaricose drugs, including sclerosing agents	0.000	0.992	0.008
Y46 Antiepileptics and anti-Parkinsonism drugs	0.000	0.992	0.008
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.992	0.008
Y42.1 Thyroid hormones and substitutes	0.000	0.992	0.008
M41.99 Scoliosis, unspecified (Site unspecified)	0.008	0.992	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.000	0.992	0.008
Y46.4 Iminostilbenes	0.000	0.992	0.008
Y49 Psychotropic drugs, not elsewhere classified	0.000	0.992	0.007
Y54.0 Mineralocorticoids	0.000	0.992	0.007
Y42.9 Other and unspecified hormone antagonists	0.000	0.992	0.007
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.993	0.007
Y54.5 Other diuretics	0.000	0.993	0.007
Y54.8 Agents affecting uric acid metabolism	0.000	0.993	0.007
Y54.9 Mineral salts, not elsewhere classified	0.000	0.993	0.007
Y54.6 Electrolytic, caloric and water-balance agents	0.000	0.993	0.007
Y54.2 Carbonic-anhydrase inhibitors	0.000	0.993	0.007
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.993	0.007
Y54.7 Agents affecting calcification	0.000	0.993	0.007
Y42.2 Antithyroid drugs	0.000	0.993	0.007
Y54.4 Loop [high-ceiling] diuretics	0.000	0.993	0.007
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.993	0.007
Y49.2 Other and unspecified antidepressants	0.000	0.993	0.007
Y59 Other and unspecified vaccines and biological substances	0.000	0.993	0.007
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.007	0.993	0.000
Y58 Bacterial vaccines	0.000	0.993	0.007
M41.96 Scoliosis, unspecified (Lumbar region)	0.007	0.993	0.000
Y57.7 Vitamins, not elsewhere classified	0.000	0.993	0.007
Y57.4 Pharmaceutical excipients	0.000	0.993	0.007
Y57.3 Alcohol deterrents	0.000	0.993	0.007
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.000	0.993	0.007
Y57.1 Lipotropic drugs	0.000	0.993	0.007
Y57.0 Appetite depressants [anorectics]	0.000	0.993	0.007
M41.9 Scoliosis, unspecified	0.007	0.993	0.000
Y42.4 Oral contraceptives	0.000	0.993	0.007
Y47.1 Benzodiazepines	0.000	0.993	0.007
Y50 Central nervous system stimulants, not elsewhere classified	0.000	0.993	0.006
Y57.6 Other diagnostic agents	0.000	0.993	0.006
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.000	0.993	0.006
Y40 Systemic antibiotics	0.000	0.994	0.006
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.994	0.006
Y46.6 Other and unspecified antiepileptics	0.000	0.994	0.006
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.994	0.006
Y48 Anaesthetics and therapeutic gases	0.000	0.994	0.006
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.994	0.006
Y46.8 Antispasticity drugs	0.000	0.994	0.006
Y46.7 Anti-Parkinsonism drugs	0.000	0.994	0.006
Y46.3 Deoxybarbiturates	0.000	0.994	0.006
Y46.1 Oxazolidinediones	0.000	0.994	0.006
Y46.0 Succinimides	0.000	0.994	0.006
Y40.9 Systemic antibiotic, unspecified	0.000	0.994	0.006
Y46.2 Hydantoin derivatives	0.000	0.994	0.006
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.000	0.994	0.006
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.000	0.994	0.006
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.000	0.994	0.006
Y47.4 Bromine compounds	0.000	0.994	0.006
Y47.3 Paraldehyde	0.000	0.994	0.006
Y47.2 Chloral derivatives	0.000	0.994	0.006
Y47.0 Barbiturates, not elsewhere classified	0.000	0.994	0.006
Y46.5 Valproic acid	0.000	0.994	0.006
Y51 Drugs primarily affecting the autonomic nervous system	0.000	0.994	0.006
Y40.7 Antifungal antibiotics, systemically used	0.000	0.994	0.006
Y49.9 Psychotropic drug, unspecified	0.000	0.994	0.006
Y49.7 Psychostimulants with abuse potential	0.000	0.994	0.006
Y49.6 Psychodysleptics [hallucinogens]	0.000	0.994	0.006
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.994	0.006
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.006	0.994	0.000
H02.4 Ptosis of eyelid	0.000	0.994	0.006
Y49.8 Other psychotropic drugs, not elsewhere classified	0.000	0.994	0.005
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.994	0.005
Y59.3 Immunoglobulin	0.000	0.995	0.005
Y49.5 Other antipsychotics and neuroleptics	0.000	0.995	0.005
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)	0.005	0.995	0.000
Y59.0 Viral vaccines	0.000	0.995	0.005
Y59.9 Vaccine or biological substance, unspecified	0.000	0.995	0.005
Y59.8 Other specified vaccines and biological substances	0.000	0.995	0.005
Y59.2 Protozoal vaccines	0.000	0.995	0.005
Y59.1 Rickettsial vaccines	0.000	0.995	0.005
Y40.8 Other systemic antibiotics	0.000	0.995	0.005
Y58.9 Other and unspecified bacterial vaccines	0.000	0.995	0.005
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.000	0.995	0.005
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.000	0.995	0.005
Y58.5 Diphtheria vaccine	0.000	0.995	0.005
Y58.4 Tetanus vaccine	0.000	0.995	0.005
Y58.3 Plague vaccine	0.000	0.995	0.005
Y58.2 Cholera vaccine	0.000	0.995	0.005
Y58.1 Typhoid and paratyphoid vaccine	0.000	0.995	0.005
Y58.0 BCG vaccine	0.000	0.995	0.005
M41.93 Scoliosis, unspecified (Cervicothoracic region)	0.005	0.995	0.000
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)	0.005	0.995	0.000
Y40.5 Aminoglycosides	0.000	0.995	0.005
Y44 Agents primarily affecting blood constituents	0.000	0.995	0.005
Y50.9 Central nervous system stimulant, unspecified	0.000	0.995	0.005
Y50.8 Other central nervous system stimulants	0.000	0.995	0.005
Y50.1 Opioid receptor antagonists	0.000	0.995	0.005
Y50.0 Analeptics	0.000	0.995	0.005
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.005	0.995	0.000
Y56.9 Topical agent, unspecified	0.000	0.995	0.005
Y56.8 Other topical agents	0.000	0.995	0.005
Y56.7 Dental drugs, topically applied	0.000	0.995	0.005
Y56.6 Otorhinolaryngological drugs and preparations	0.000	0.995	0.005
Y56.5 Ophthalmological drugs and preparations	0.000	0.995	0.005
Y56.2 Local astringents and local detergents	0.000	0.995	0.005
Y56.1 Antipruritics	0.000	0.995	0.005
M41.97 Scoliosis, unspecified (Lumbosacral region)	0.005	0.995	0.000
Y57.5 X-ray contrast media	0.000	0.995	0.005
Y40.6 Rifamycins	0.000	0.995	0.005
Y40.2 Chloramphenicol group	0.000	0.995	0.005
Y55.4 Expectorants	0.000	0.995	0.005
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.995	0.005
Z49.1 Extracorporeal dialysis	0.005	0.995	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.000	0.995	0.005
M41.92 Scoliosis, unspecified (Cervical region)	0.005	0.995	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.000	0.995	0.005
Y56.3 Emollients, demulcents and protectants	0.000	0.995	0.005
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.995	0.005
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.995	0.004
Y55.5 Anticommon cold drugs	0.000	0.995	0.004
Y55.3 Antitussives	0.000	0.995	0.004
Y55.2 Other and unspecified agents primarily acting on muscles	0.000	0.995	0.004
Y55.0 Oxytocic drugs	0.000	0.995	0.004
Y48.5 Therapeutic gases	0.000	0.995	0.004
Y48.1 Parenteral anaesthetics	0.000	0.995	0.004
Y48.0 Inhaled anaesthetics	0.000	0.995	0.004
Y43 Primarily systemic agents	0.000	0.995	0.005
Y48.3 Local anaesthetics	0.000	0.995	0.004
Y49.0 Tricyclic and tetracyclic antidepressants	0.000	0.995	0.004
Z63.4 Disappearance and death of family member	0.000	0.995	0.005
Y48.4 Anaesthetic, unspecified	0.000	0.995	0.004
O75.7 Vaginal delivery following previous Caesarean section	0.000	0.995	0.005
M19.07 Primary arthrosis of other joints (Ankle and foot)	0.000	0.995	0.005
Y40.4 Tetracyclines	0.000	0.995	0.004
M41.94 Scoliosis, unspecified (Thoracic region)	0.004	0.996	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.000	0.996	0.004
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.996	0.004
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.996	0.004
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.996	0.004
Y51.1 Other parasympathomimetics [cholinergics]	0.000	0.996	0.004
Y51.0 Anticholinesterase agents	0.000	0.996	0.004
Y55.6 Antiasthmatics, not elsewhere classified	0.000	0.996	0.004
Y41 Other systemic anti-infectives and antiparasitics	0.000	0.996	0.004
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.996	0.004
Y40.1 Cefalosporins and other -lactam antibiotics	0.000	0.996	0.004
Y43.4 Immunosuppressive agents	0.000	0.996	0.004
Y48.2 Other and unspecified general anaesthetics	0.000	0.996	0.004
M41 Scoliosis	0.004	0.996	0.000
Z04.8 Examination and observation for other specified reasons	0.004	0.996	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.996	0.004
J92.0 Pleural plaque with presence of asbestos	0.000	0.996	0.004
Y44.9 Other and unspecified agents affecting blood constituents	0.000	0.996	0.004
Y44.7 Plasma substitutes	0.000	0.996	0.004
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.000	0.996	0.004
K61.0 Anal abscess	0.004	0.996	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.996	0.004
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.000	0.996	0.004
Z49.2 Other dialysis	0.004	0.996	0.000
Z63 Other problems related to primary support group, including family circumstances	0.000	0.996	0.004
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.000	0.996	0.004
H57.1 Ocular pain	0.000	0.996	0.004
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.000	0.996	0.004
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.996	0.003
Y53.7 Emetics	0.000	0.996	0.003
Y53.5 Digestants	0.000	0.996	0.003
Y53.0 Histamine H2-receptor antagonists	0.000	0.996	0.003
Y43.2 Antineoplastic natural products	0.000	0.996	0.004
Y53.6 Antidiarrhoeal drugs	0.000	0.996	0.003
Y53.3 Saline and osmotic laxatives	0.000	0.996	0.003
Y44.5 Thrombolytic drugs	0.000	0.996	0.003
Z49 Care involving dialysis	0.004	0.996	0.000
Y43.9 Primarily systemic agent, unspecified	0.000	0.996	0.003
Y43.8 Other primarily systemic agents, not elsewhere classified	0.000	0.996	0.003
Y43.6 Enzymes, not elsewhere classified	0.000	0.996	0.003
Y43.5 Acidifying and alkalising agents	0.000	0.996	0.003
Y53.4 Other laxatives	0.000	0.996	0.003
Y43.0 Antiallergic and antiemetic drugs	0.000	0.996	0.003
Y44.6 Natural blood and blood products	0.000	0.996	0.003
Y40.3 Macrolides	0.000	0.996	0.003
Y53.2 Stimulant laxatives	0.000	0.996	0.003
Y44.2 Anticoagulants	0.000	0.997	0.003
Z63.5 Disruption of family by separation and divorce	0.000	0.997	0.003
Z63.7 Other stressful life events affecting family and household	0.000	0.997	0.003
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
Y41.4 Anthelminthics	0.000	0.997	0.003
Y41.3 Other antiprotozoal drugs	0.000	0.997	0.003
Z58.1 Exposure to air pollution	0.000	0.997	0.003
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
Z63.8 Other specified problems related to primary support group	0.000	0.997	0.003
M41.2 Other idiopathic scoliosis	0.003	0.997	0.000
Y41.1 Antimycobacterial drugs	0.000	0.997	0.003
D11.0 Parotid gland	0.003	0.997	0.000
M41.8 Other forms of scoliosis	0.003	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
M41.3 Thoracogenic scoliosis	0.003	0.997	0.000
M41.1 Juvenile idiopathic scoliosis	0.003	0.997	0.000
M41.0 Infantile idiopathic scoliosis	0.003	0.997	0.000
M41.4 Neuromuscular scoliosis	0.003	0.997	0.000
Y41.0 Sulphonamides	0.000	0.997	0.003
Y42.5 Other oestrogens and progestogens	0.002	0.997	0.001
Y53.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.003
M41.5 Other secondary scoliosis	0.003	0.997	0.000
Z63.6 Dependent relative needing care at home	0.000	0.997	0.003
Z49.0 Preparatory care for dialysis	0.003	0.997	0.000
Y41.5 Antiviral drugs	0.000	0.997	0.003
Z63.9 Problem related to primary support group, unspecified	0.000	0.997	0.003
Z63.3 Absence of family member	0.000	0.997	0.003
Z63.2 Inadequate family support	0.000	0.997	0.003
Z63.1 Problems in relationship with parents and in-laws	0.000	0.997	0.003
C64 Malignant neoplasm of kidney, except renal pelvis	0.003	0.997	0.000
Z58 Problems related to physical environment	0.000	0.997	0.003
S64.4 Injury of digital nerve of other finger	0.003	0.997	0.000
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.000	0.997	0.003
Z58.5 Exposure to other pollution	0.000	0.997	0.003
M54.18 Radiculopathy (Sacral and sacrococcygeal region)	0.003	0.997	0.000
Z61 Problems related to negative life events in childhood	0.000	0.997	0.003
Z56.0 Unemployment, unspecified	0.000	0.997	0.003
M41.80 Other forms of scoliosis (Multiple sites in spine)	0.002	0.997	0.000
Z56 Problems related to employment and unemployment	0.000	0.997	0.003
M41.29 Other idiopathic scoliosis (Site unspecified)	0.002	0.997	0.000
B37.9 Candidiasis, unspecified	0.000	0.997	0.003
R00.8 Other and unspecified abnormalities of heart beat	0.000	0.997	0.003
M41.28 Other idiopathic scoliosis (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M41.27 Other idiopathic scoliosis (Lumbosacral region)	0.002	0.997	0.000
M41.26 Other idiopathic scoliosis (Lumbar region)	0.002	0.997	0.000
M41.25 Other idiopathic scoliosis (Thoracolumbar region)	0.002	0.997	0.000
M41.24 Other idiopathic scoliosis (Thoracic region)	0.002	0.997	0.000
M41.23 Other idiopathic scoliosis (Cervicothoracic region)	0.002	0.997	0.000
M41.22 Other idiopathic scoliosis (Cervical region)	0.002	0.997	0.000
M41.21 Other idiopathic scoliosis (Occipito-atlanto-axial region)	0.002	0.997	0.000
M41.20 Other idiopathic scoliosis (Multiple sites in spine)	0.002	0.997	0.000
Y40.0 Penicillins	0.000	0.997	0.002
Z61.6 Problems related to alleged physical abuse of child	0.000	0.997	0.002
M41.86 Other forms of scoliosis (Lumbar region)	0.002	0.997	0.000
M41.89 Other forms of scoliosis (Site unspecified)	0.002	0.997	0.000
M41.88 Other forms of scoliosis (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M41.87 Other forms of scoliosis (Lumbosacral region)	0.002	0.997	0.000
M41.84 Other forms of scoliosis (Thoracic region)	0.002	0.997	0.000
M41.83 Other forms of scoliosis (Cervicothoracic region)	0.002	0.997	0.000
M41.82 Other forms of scoliosis (Cervical region)	0.002	0.997	0.000
M41.81 Other forms of scoliosis (Occipito-atlanto-axial region)	0.002	0.997	0.000
S46.0 Injury of tendon of the rotator cuff of shoulder	0.000	0.997	0.003
M41.09 Infantile idiopathic scoliosis (Site unspecified)	0.002	0.997	0.000
M41.08 Infantile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M41.07 Infantile idiopathic scoliosis (Lumbosacral region)	0.002	0.997	0.000
M41.06 Infantile idiopathic scoliosis (Lumbar region)	0.002	0.997	0.000
M41.05 Infantile idiopathic scoliosis (Thoracolumbar region)	0.002	0.997	0.000
M41.04 Infantile idiopathic scoliosis (Thoracic region)	0.002	0.997	0.000
M41.03 Infantile idiopathic scoliosis (Cervicothoracic region)	0.002	0.997	0.000
M41.02 Infantile idiopathic scoliosis (Cervical region)	0.002	0.997	0.000
M41.01 Infantile idiopathic scoliosis (Occipito-atlanto-axial region)	0.002	0.997	0.000
M41.00 Infantile idiopathic scoliosis (Multiple sites in spine)	0.002	0.997	0.000
M41.19 Juvenile idiopathic scoliosis (Site unspecified)	0.002	0.997	0.000
M41.18 Juvenile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M41.17 Juvenile idiopathic scoliosis (Lumbosacral region)	0.002	0.997	0.000
M41.16 Juvenile idiopathic scoliosis (Lumbar region)	0.002	0.997	0.000
M41.15 Juvenile idiopathic scoliosis (Thoracolumbar region)	0.002	0.997	0.000
M41.14 Juvenile idiopathic scoliosis (Thoracic region)	0.002	0.997	0.000
M41.13 Juvenile idiopathic scoliosis (Cervicothoracic region)	0.002	0.997	0.000
M41.12 Juvenile idiopathic scoliosis (Cervical region)	0.002	0.997	0.000
M41.11 Juvenile idiopathic scoliosis (Occipito-atlanto-axial region)	0.002	0.997	0.000
M41.10 Juvenile idiopathic scoliosis (Multiple sites in spine)	0.002	0.997	0.000
M41.39 Thoracogenic scoliosis-Site unspe	0.002	0.997	0.000
M41.38 Thoracogenic scoliosis-Sacral/sacrococ	0.002	0.997	0.000
M41.37 Thoracogenic scoliosis-Lumbosacral	0.002	0.997	0.000
M41.36 Thoracogenic scoliosis-Lumbar	0.002	0.997	0.000
M41.35 Thoracogenic scoliosis (Thoracolumbar region)	0.002	0.997	0.000
M41.34 Thoracogenic scoliosis (Thoracic region)	0.002	0.997	0.000
M41.33 Thoracogenic scoliosis (Cervicothoracic region)	0.002	0.997	0.000
M41.32 Thoracogenic scoliosis-Cervical	0.002	0.997	0.000
M41.31 Thoracogenic scoliosis-Occipit-atl-axl	0.002	0.997	0.000
M41.30 Thoracogenic scoliosis (Multiple sites in spine)	0.002	0.997	0.000
M41.48 Neuromuscular scoliosis (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M41.47 Neuromuscular scoliosis (Lumbosacral region)	0.002	0.997	0.000
M41.46 Neuromuscular scoliosis (Lumbar region)	0.002	0.997	0.000
M41.45 Neuromuscular scoliosis (Thoracolumbar region)	0.002	0.997	0.000
M41.44 Neuromuscular scoliosis (Thoracic region)	0.002	0.997	0.000
M41.43 Neuromuscular scoliosis (Cervicothoracic region)	0.002	0.997	0.000
M41.42 Neuromuscular scoliosis (Cervical region)	0.002	0.997	0.000
M41.41 Neuromuscular scoliosis (Occipito-atlanto-axial region)	0.002	0.997	0.000
M41.40 Neuromuscular scoliosis (Multiple sites in spine)	0.002	0.997	0.000
M41.54 Other secondary scoliosis (Thoracic region)	0.002	0.997	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.002
M41.49 Neuromuscular scoliosis (Site unspecified)	0.002	0.997	0.000
M41.59 Other secondary scoliosis (Site unspecified)	0.002	0.997	0.000
M41.58 Other secondary scoliosis (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M41.57 Other secondary scoliosis (Lumbosacral region)	0.002	0.997	0.000
M41.55 Other secondary scoliosis (Thoracolumbar region)	0.002	0.997	0.000
M41.53 Other secondary scoliosis (Cervicothoracic region)	0.002	0.997	0.000
M41.52 Other secondary scoliosis (Cervical region)	0.002	0.997	0.000
M41.51 Other secondary scoliosis (Occipito-atlanto-axial region)	0.002	0.997	0.000
M41.50 Other secondary scoliosis (Multiple sites in spine)	0.002	0.997	0.000
Y43.1 Antineoplastic antimetabolites	0.000	0.997	0.002
M41.85 Other forms of scoliosis (Thoracolumbar region)	0.002	0.997	0.000
Z58.9 Problem related to physical environment, unspecified	0.000	0.998	0.002
Z58.6 Inadequate drinking-water supply	0.000	0.998	0.002
Z58.4 Exposure to radiation	0.000	0.998	0.002
Z58.3 Exposure to soil pollution	0.000	0.998	0.002
Z58.2 Exposure to water pollution	0.000	0.998	0.002
Z58.0 Exposure to noise	0.000	0.998	0.002
K61.3 Ischiorectal abscess	0.002	0.998	0.000
H91.9 Hearing loss, unspecified	0.002	0.998	0.000
Z64 Problems related to certain psychosocial circumstances	0.000	0.998	0.002
M41.56 Other secondary scoliosis (Lumbar region)	0.002	0.998	0.000
G61.8 Other inflammatory polyneuropathies	0.000	0.998	0.002
K61 Abscess of anal and rectal regions	0.002	0.998	0.000
Z62 Other problems related to upbringing	0.000	0.998	0.002
Z55 Problems related to education and literacy	0.000	0.998	0.002
Z58.7 Exposure to tobacco smoke	0.000	0.998	0.002
Z65 Problems related to other psychosocial circumstances	0.000	0.998	0.002
Z61.4 Problems related to alleged sexual abuse of child by person within primary support group	0.000	0.998	0.002
M20.4 Other hammer toe(s) (acquired)	0.002	0.998	0.000
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.002	0.998	0.000
T92.1 Sequelae of fracture of arm	0.002	0.998	0.000
Z56.3 Stressful work schedule	0.000	0.998	0.002
Z61.9 Negative life events in childhood, unspecified	0.000	0.998	0.002
Z61.8 Other negative life events in childhood	0.000	0.998	0.002
Z61.7 Personal frightening experience in childhood	0.000	0.998	0.002
Z61.3 Events resulting in loss of self-esteem in childhood	0.000	0.998	0.002
Z61.2 Altered pattern of family relationships in childhood	0.000	0.998	0.002
Z61.1 Removal from home in childhood	0.000	0.998	0.002
Z61.0 Loss of love relationship in childhood	0.000	0.998	0.002
Z59 Problems related to housing and economic circumstances	0.000	0.998	0.002
Z56.6 Other physical and mental strain related to work	0.000	0.998	0.002
Z58.8 Other problems related to physical environment	0.000	0.998	0.002
Z61.5 Problems related to alleged sexual abuse of child by person outside primary support group	0.000	0.998	0.002
Z56.5 Uncongenial work	0.000	0.998	0.002
Z56.2 Threat of job loss	0.000	0.998	0.002
Z56.1 Change of job	0.000	0.998	0.002
M54.16 Radiculopathy (Lumbar region)	0.002	0.998	0.000
S64.3 Injury of digital nerve of thumb	0.002	0.998	0.000
Z64.0 Problems related to unwanted pregnancy	0.000	0.998	0.002
S82.40 Fracture of fibula alone (closed)	0.000	0.998	0.002
O75.0 Maternal distress during labour and delivery	0.000	0.998	0.002
K61.1 Rectal abscess	0.002	0.998	0.000
Z57.5 Occupational exposure to toxic agents in other industries	0.000	0.998	0.002
S64 Injury of nerves at wrist and hand level	0.002	0.998	0.000
B37.8 Candidiasis of other sites	0.000	0.998	0.002
C90.0 Multiple myeloma	0.000	0.998	0.002
H49.0 Third [oculomotor] nerve palsy	0.000	0.998	0.002
L60.8 Other nail disorders	0.000	0.998	0.002
S64.2 Injury of radial nerve at wrist and hand level	0.002	0.998	0.000
Z56.7 Other and unspecified problems related to employment	0.000	0.998	0.002
Z56.4 Discord with boss and workmates	0.000	0.998	0.002
Z63.0 Problems in relationship with spouse or partner	0.000	0.998	0.002
K63.3 Ulcer of intestine	0.000	0.998	0.002
Z64.4 Discord with counsellors	0.000	0.998	0.002
Z64.3 Seeking and accepting behavioural and psychological interventions known to be hazardous and harmful	0.000	0.998	0.002
Z64.2 Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful	0.000	0.998	0.002
Z64.1 Problems related to multiparity	0.000	0.998	0.002
M54.1 Radiculopathy	0.002	0.998	0.000
Y43.3 Other antineoplastic drugs	0.000	0.998	0.002
O75 Other complications of labour and delivery, not elsewhere classified	0.000	0.998	0.002
Z57 Occupational exposure to risk-factors	0.000	0.998	0.002
Z59.0 Homelessness	0.000	0.998	0.002
Z65.9 Problem related to unspecified psychosocial circumstances	0.000	0.998	0.002
O36.5 Maternal care for poor foetal growth	0.000	0.998	0.002
F33.9 Recurrent depressive disorder, unspecified	0.002	0.998	0.000
H47.2 Optic atrophy	0.002	0.998	0.000
Z55.9 Problems relating to education and literacy, unspecified	0.000	0.998	0.002
Z55.8 Other problems relating to education and literacy	0.000	0.998	0.002
Z55.4 Educational maladjustment and discord with teachers and classmates	0.000	0.998	0.002
Z55.3 Underachievement in school	0.000	0.998	0.002
Z55.2 Failed examinations	0.000	0.998	0.002
Z55.1 Schooling unavailable and unattainable	0.000	0.998	0.002
Z55.0 Illiteracy and low-level literacy	0.000	0.998	0.002
Z59.2 Discord with neighbours, lodgers and landlord	0.000	0.998	0.002
Z62.9 Problem related to upbringing, unspecified	0.000	0.998	0.002
Z62.8 Other specified problems related to upbringing	0.000	0.998	0.002
Z62.6 Inappropriate parental pressure and other abnormal qualities of upbringing	0.000	0.998	0.002
Z62.5 Other problems related to neglect in upbringing	0.000	0.998	0.002
Z62.4 Emotional neglect of child	0.000	0.998	0.002
Z62.3 Hostility towards and scapegoating of child	0.000	0.998	0.002
Z62.2 Institutional upbringing	0.000	0.998	0.002
Z62.1 Parental overprotection	0.000	0.998	0.002
Z62.0 Inadequate parental supervision and control	0.000	0.998	0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.002	0.998	0.000
H52.3 Anisometropia and aniseikonia	0.000	0.998	0.002
Z65.5 Exposure to disaster, war and other hostilities	0.000	0.998	0.002
Z65.4 Victim of crime and terrorism	0.000	0.998	0.002
Z65.2 Problems related to release from prison	0.000	0.998	0.002
Z65.1 Imprisonment and other incarceration	0.000	0.998	0.002
Z65.0 Conviction in civil and criminal proceedings without imprisonment	0.000	0.998	0.002
B37 Candidiasis	0.000	0.998	0.002
M40-M43 Deforming dorsopathies	0.002	0.998	0.000
S82.20 Fracture of shaft of tibia (closed)	0.000	0.998	0.002
Z59.4 Lack of adequate food	0.000	0.998	0.002
K61.2 Anorectal abscess	0.002	0.998	0.000
Z59.9 Problem relating to housing and economic circumstances, unspecified	0.000	0.998	0.002
Z65.3 Problems related to other legal circumstances	0.000	0.998	0.002
N70.1 Chronic salpingitis and oophoritis	0.000	0.998	0.002
Z22.5 Carrier of viral hepatitis	0.002	0.998	0.000
Z65.8 Other specified problems related to psychosocial circumstances	0.000	0.998	0.002
Z59.7 Insufficient social insurance and welfare support	0.000	0.998	0.002
Z59.6 Low income	0.000	0.998	0.002
Z59.5 Extreme poverty	0.000	0.998	0.002
Z59.3 Problems related to living in residential institution	0.000	0.998	0.002
K61.4 Intrasphincteric abscess	0.002	0.998	0.000
O75.3 Other infection during labour	0.000	0.998	0.002
B37.2 Candidiasis of skin and nail	0.000	0.998	0.002
M19.09 Primary arthrosis of other joints (Site unspecified)	0.000	0.998	0.002
M54.12 Radiculopathy (Cervical region)	0.002	0.998	0.000
B37.7 Candidal septicaemia	0.000	0.998	0.002
M54.17 Radiculopathy (Lumbosacral region)	0.002	0.998	0.000
B37.3 Candidiasis of vulva and vagina	0.000	0.998	0.002
M40 Kyphosis and lordosis	0.002	0.998	0.000
M54.14 Radiculopathy (Thoracic region)	0.002	0.998	0.000
C67.6 Ureteric orifice	0.002	0.998	0.000
Z59.1 Inadequate housing	0.000	0.998	0.002
M19.0 Primary arthrosis of other joints	0.000	0.998	0.002
S64.9 Injury of unspecified nerve at wrist and hand level	0.002	0.998	0.000
S64.8 Injury of other nerves at wrist and hand level	0.002	0.998	0.000
M19.02 Primary arthrosis of other joints (Upper arm)	0.000	0.998	0.002
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.000	0.998	0.002
O75.5 Delayed delivery after artificial rupture of membranes	0.000	0.998	0.002
M54.15 Radiculopathy (Thoracolumbar region)	0.002	0.998	0.000
M54.11 Radiculopathy (Occipito-atlanto-axial region)	0.002	0.998	0.000
O75.4 Other complications of obstetric surgery and procedures	0.000	0.998	0.002
O75.1 Shock during or following labour and delivery	0.000	0.998	0.002
Z57.9 Occupational exposure to unspecified risk-factor	0.000	0.998	0.002
Z57.8 Occupational exposure to other risk-factors	0.000	0.998	0.002
Z57.7 Occupational exposure to vibration	0.000	0.998	0.002
Z57.6 Occupational exposure to extreme temperature	0.000	0.998	0.002
Z57.4 Occupational exposure to toxic agents in agriculture	0.000	0.998	0.002
Z57.1 Occupational exposure to radiation	0.000	0.998	0.002
Z57.0 Occupational exposure to noise	0.000	0.998	0.002
D26.0 Cervix uteri	0.000	0.998	0.002
S64.1 Injury of median nerve at wrist and hand level	0.002	0.998	0.000
B49 Unspecified mycosis	0.000	0.998	0.002
M54.13 Radiculopathy (Cervicothoracic region)	0.002	0.998	0.000
S64.0 Injury of ulnar nerve at wrist and hand level	0.002	0.998	0.000
M42 Spinal osteochondrosis	0.002	0.998	0.000
M54.10 Radiculopathy (Multiple sites in spine)	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.001
T50.5 Appetite depressants	0.000	0.998	0.001
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.001
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.001
B37.6 Candidal endocarditis	0.000	0.998	0.002
B37.5 Candidal meningitis	0.000	0.998	0.002
S64.7 Injury of multiple nerves at wrist and hand level	0.001	0.998	0.000
M40.5 Lordosis, unspecified	0.001	0.998	0.000
O75.9 Complication of labour and delivery, unspecified	0.000	0.998	0.001
H01.0 Blepharitis	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.001
M25.96 Joint disorder, unspecified (Lower leg)	0.000	0.998	0.002
M40.2 Other and unspecified kyphosis	0.001	0.998	0.000
N83.1 Corpus luteum cyst	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.001
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.001
C64-C68 Malignant neoplasms of urinary tract	0.002	0.998	0.000
M43.09 Spondylolysis (Site unspecified)	0.001	0.998	0.000
M54.19 Radiculopathy (Site unspecified)	0.001	0.998	0.000
M19.08 Primary arthrosis of other joints (Other)	0.000	0.998	0.001
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.001
Z59.8 Other problems relating to housing and economic circumstances	0.000	0.998	0.001
M40.4 Other lordosis	0.001	0.998	0.000
M40.3 Flatback syndrome	0.001	0.998	0.000
M40.0 Postural kyphosis	0.001	0.998	0.000
M19.05 Primary arthrosis of other joints (Pelvic region and thigh)	0.000	0.998	0.001
M40.29 Other and unspecified kyphosis (Site unspecified)	0.001	0.998	0.000
I87.2 Venous insufficiency (chronic) (peripheral)	0.000	0.998	0.002
M40.1 Other secondary kyphosis	0.001	0.998	0.000
M19.00 Primary arthrosis of other joints (Multiple sites)	0.000	0.998	0.001
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
C67.0 Trigone of bladder	0.001	0.998	0.000
T50.8 Diagnostic agents	0.000	0.998	0.001
M19.06 Primary arthrosis of other joints-Lower leg	0.000	0.998	0.001
M40.52 Lordosis, unspecified (Cervical region)	0.001	0.998	0.000
D26.9 Uterus, unspecified	0.000	0.998	0.001
M42.0 Juvenile osteochondrosis of spine	0.001	0.998	0.000
Z60 Problems related to social environment	0.000	0.998	0.001
S06.90 Intracranial injury, unspecified (without open intracranial wound)	0.000	0.998	0.001
C67 Malignant neoplasm of bladder	0.002	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.001	0.998	0.001
C67.2 Lateral wall of bladder	0.001	0.999	0.000
M42.9 Spinal osteochondrosis, unspecified	0.001	0.999	0.000
M42.1 Adult osteochondrosis of spine	0.001	0.999	0.000
Z97.5 Presence of (intra-uterine) contraceptive device	0.001	0.999	0.000
M40.56 Lordosis, unspecified (Lumbar region)	0.001	0.999	0.000
Q66.8 Other congenital deformities of feet	0.000	0.999	0.001
F33 Recurrent depressive disorder	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations